WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |

Search International and National Patent Collections
World Intellectual Property Organization
Machine translation
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2006/084560    International Application No.:    PCT/EP2006/000501
Publication Date: 17.08.2006 International Filing Date: 20.01.2006
A23C 9/13 (2006.01), A23L 1/30 (2006.01), A61K 31/21 (2006.01), A23L 1/305 (2006.01), A61K 38/01 (2006.01), A61K 38/05 (2006.01), A61K 38/06 (2006.01), A61K 31/525 (2006.01)
Applicants: UNILEVER N.V. [NL/NL]; Weena 455, NL-3013 AL Rotterdam (NL) (AL, AM, AT, AZ, BA, BE, BF, BG, BJ, BR, BY, CF, CG, CH, CI, CM, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, ES, FI, FR, GA, GE, GN, GQ, GR, GW, HR, HU, ID, IS, IT, JP, KG, KM, KP, KR, KZ, LR, LT, LU, LV, MA, MC, MD, MG, MK, ML, MR, MX, MZ, NE, NI, NL, NO, PH, PL, PT, RO, RU, SE, SI, SK, SM, SN, SY, TD, TG, TJ, TM, TN, TR, UA, UZ, VN, YU only).
UNILEVER PLC [GB/GB]; Unilever House, Blackfriars, London Greater London EC4P 4BQ (GB) (AE, AG, AU, BB, BW, BZ, CA, CY, EG, GB, GD, GH, GM, IE, IL, KE, KN, LC, LK, LS, LY, MN, MW, NA, NG, NZ, OM, PG, SC, SD, SG, SL, SZ, TT, TZ, UG, VC, ZA, ZM, ZW only).
HINDUSTAN UNILEVER LIMITED [IN/IN]; Hindustan Lever House, 165/166 Backbay Reclamation, Maharashtra, Mumbai 400 020 (IN) (IN only).
BREE, Angelika, De [NL/NL]; (NL) (For US Only).
GERHARDT, Cinderella, Christina [NL/NL]; (NL) (For US Only)
Inventors: BREE, Angelika, De; (NL).
GERHARDT, Cinderella, Christina; (NL)
Agent: JOPPE, Hermina, Laura, Petr; Unilever Patent Group, Olivier van Noortlaan 120, NL-3133 AT Vlaardingen (NL)
Priority Data:
05075323.5 09.02.2005 EP
05076051.1 28.04.2005 EP
Abstract: front page image
(EN)Composition comprising one or more peptide and one or more B-vitamins. Preferably the ACE inhibiting peptides are chosen from tripeptides and/or dipeptides, more preferably from VPP, IPP, LPP, VY, VF, IW, HLPLP, VAP, AW, LW, HLP, IY, FY, PPL, YP, TPP, and MPP.
(FR)L'invention concerne une composition comprenant un ou plusieurs peptides et une ou plusieurs vitamines B. On choisit de préférence les peptides inhibant l'enzyme de conversion de l'angiotensine parmi des tripeptides et/ou des dipeptides, plus préférablement VPP, IPP, LPP, VY, VF, IW, HLPLP, VAP, AW, LW, HLP, IY, FY, PPL, YP, TPP et MPP.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, LY, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)